Christopher Rovaldi

Insider Reports History

Entity
Individual
Location
C/O Acceleron Pharma Inc., 128 Sidney St., Cambridge, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Rovaldi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. CHIEF OPERATING OFFICER Employee Stock Option (right to buy) 150K Feb 13, 2024 Direct

Insider Reports Filed by Christopher Rovaldi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 CHIEF OPERATING OFFICER
KROS Keros Therapeutics, Inc. Feb 16, 2023 1 $0 4 Feb 17, 2023 Chief Operating Officer
KROS Keros Therapeutics, Inc. Apr 6, 2022 3 -$84.7K 4 Apr 8, 2022 Chief Operating Officer
KROS Keros Therapeutics, Inc. Apr 1, 2022 7 -$35.9K 4 Apr 5, 2022 Chief Operating Officer
KROS Keros Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Operating Officer
KROS Keros Therapeutics, Inc. Feb 1, 2022 0 $0 3 Feb 3, 2022 Chief Operating Officer